ICICI Pru MNC Fund
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities within MNC space.
Growthvine rating: 4/5 — ranked #36 of 179 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹31.16 (as of 2026-08-21) |
|---|
| AUM | ₹1,806 Cr |
|---|
| Expense ratio | 1.78% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Roshan Chutkey |
|---|
| Exit load | 1% for redemption within 1 month |
|---|
Performance & risk
| 5-year annualised return | 12.48% |
|---|
| Sharpe ratio | 0.48 |
|---|
| Standard deviation | 13.48% |
|---|
| Max drawdown | -30.90% |
|---|
| Alpha | 0.89 |
|---|
| Beta | 0.83 |
|---|
Over 5 years, captured 40.8% of NIFTY CPSE's upside and 41.1% of its downside.
Market cap allocation
| Large cap | 45.9% |
|---|
| Mid cap | 22.2% |
|---|
| Small cap | 31.9% |
|---|
Concentration
| Top 5 holdings | 27.8% |
|---|
| Top 10 holdings | 46.1% |
|---|
| Total holdings | 54 |
|---|
Top holdings
- Hindustan Unilever Ltd. — 7.5%
- Maruti Suzuki India Ltd. — 6.0%
- Britannia Industries Ltd. — 5.1%
- Nestle India Ltd. — 5.0%
- Sona BLW Precision Forgings Limited — 4.3%
- Sun Pharmaceutical Industries Ltd. — 4.2%
- Vedanta Aluminium Metal Limited — 4.0%
- HYUNDAI MOTOR INDIA LIMITED — 3.8%
- United Spirits Limited — 3.2%
- Gland Pharma Limited — 3.1%
Top sectors
- Automobile — 21.5%
- Pharma & Biotech — 17.2%
- Food Beverage & Tobacco — 15.3%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 5.7% | Q2 | #66 of 167 |
| 2025 | 5.4% | Q2 | #55 of 132 |
| 2024 | 16.4% | Q3 | #64 of 86 |
| 2023 | 26.5% | Q3 | #45 of 66 |
| 2022 | -0.4% | Q3 | #34 of 55 |